Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

NKTR Price Correlated With Financials For Nektar Therapeutics

Free historical financial statements for Nektar Therapeutics. See how revenue, income, cash flow, and balance sheet financials have changed over 45 quarters since 2011. Compare with NKTR stock chart to see long term trends.

NKTR Stock Compared to Quarterly

NKTR Income Statement

Revenue, Net:24822000
Revenue Per Share:0.1333
Cost of Goods & Services Sold:5315000
Selling, General & Admin Expense:27339000
Research & Development Expense:107253000
Total Operating Expenses:141382000
Operating Income:-116560000
Income Taxes:126000
Net Income:-90393000
Earnings Per Share, Basic:-0.49
Shares Outstanding, Basic Avg:186274156

NKTR Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:3730000
Change in Accounts Receiveable:7728000
Net Cash from Operations:-88424000
Net Cash from Operations Per Share:-0.4747
Net Cash from Financing Activities:938000
Property, Plant & Equipment Purchases:4203000
Net Cash from Investing Activities:130278000
Net Change in Cash & Equivalents:42775000

NKTR Balance Sheet

Cash and Cash Equivalents:67993000
Accounts Receivable, Net:30220000
Total Current Assets:733455000
Property, Plant & Equipment, Net:60980000
Total Assets:1024116000
Accounts Payable:12617000
Total Short-Term Liabilities:105281000
Total Liabilities:416227000

Data imported from Nektar Therapeutics SEC filings. Check original filings before making any investment decision.